Kevin J. O'Connor, a director at Procore Applied sciences , Inc. (NYSE:PCOR), a development administration software program firm with an…
In latest transactions reported to the Securities and Trade Fee, Topline Capital Administration, LLC, led by its managing member Collin…
Alejandra Carvajal, the Senior Vice President and Chief Authorized Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), not too long ago performed…
CAMBRIDGE, MA—Bala Mohan, the Senior Vice President and Chief Improvement Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), just lately executed a…
Timothy B. Lowinger, the Senior Vice President and Chief Science & Expertise Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), not too…
CAMBRIDGE, MA—Brian DeSchuytner, Senior Vice President, Chief Working Officer, and Chief Monetary Officer of Mersana Therapeutics, Inc. (NASDAQ:MRSN), just lately…
On yesterday, January 13, 2025, Ashish acquired 2,646 shares of frequent inventory via the vesting of RSUs, with no money…
The sale was performed to cowl tax withholding obligations associated to the vesting and settlement of restricted inventory models (RSUs).…
Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a $454 million market cap biotech firm, not too long ago reported that its Chief Govt…
Adam Scott Levy, the Chief Monetary Officer and Secretary of Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a clinical-stage biotech firm with a…